反応式
CCOC(=O)c1cnc(N)o1.Clc1ccnc(Cl)c1>C1COCCO1.CC1(C)c2cccc(P(c3ccccc3)c3ccccc3)c2Oc2c(P(c3ccccc3)c3ccccc3)cccc21.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C([O-])[O-].[Cs+].[Cs+].[Pd].[Pd]>CCOC(=O)c1cnc(Nc2cc(Cl)ccn2)o1参加物
反応物 2
生成物 1
試薬・触媒・溶媒 4
反応条件
- 温度
- 160 °C
実験手順
Objective: To make the coupled product on a larger scale for hydrolysis/decarboxylation Pd2(dba)3 (80 mg, 0.09 mmol), 9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene (152 mg, 0.26 mmol), 2,4-dichloropyridine (0.378 mL, 3.50 mmol), cesium carbonate (2279 mg, 6.99 mmol) and ethyl 2-aminooxazole-5-carboxylate (546 mg, 3.50 mmol) were added to an oven dried microwave vial and the vial was capped and placed under an inert atmosphere, dioxane (18 mL) was added and the resulting mixture was heated to 160 °C for 1 h by microwave irradiation under a nitrogen atmosphere. The crude product was purified by flash silica chromatography, elution gradient 0 to 3% MeOH (7 N ammonia) in DCM. Pure fractions were evaporated to dryness to afford ethyl 2-(4-chloropyridin-2-ylamino)oxazole-5-carboxylate (892 mg, 95 %) as a brown solid. Analysis of the product after chromatography showed that it was ~ 75% pure by proton NMR and LCMS, therefore the actual yield of the desired product is closer to 70%. Note: the reaction was carried out twice on the above scale.
出典と根拠
- ORDレコード
- ord-5d8d88656735435b992c60c9f2e9cc2e
- 出典データセット
- 750 AstraZeneca ELN dataset
- 元リンク
- 出典を表示
関連ノート
読み込み中…